Revenue: The sum of all revenue fields included for a company's operating activities.
ABVC BioPharma, Inc. (ABVC) had Revenue of $0.80M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$0.80M |
$-1.25M |
|
-- |
|
$0.80M |
|
$1.96M |
|
$-1.17M |
|
$-0.12M |
|
$-1.29M |
|
$-1.23M |
|
$-1.29M |
|
$-1.29M |
|
$-1.29M |
|
$-1.23M |
|
$-1.17M |
|
$-1.07M |
|
23.26M |
|
23.26M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$4.07M |
|
$12.06M |
|
$17.10M |
|
$21.18M |
|
$6.51M |
|
-- |
|
$0.18M |
|
$6.68M |
|
$14.49M |
|
$14.49M |
|
$14.49M |
|
23.46M |
|
| Cash Flow Statement Financials | |
$-1.57M |
|
$-1.94M |
|
$3.49M |
|
$0.86M |
|
$0.85M |
|
$-0.01M |
|
$2.76M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.63 |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
100.00% |
|
-146.79% |
|
-146.79% |
|
-- |
|
-161.69% |
|
-156.61% |
|
$-1.57M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-8.88% |
|
-8.88% |
|
-6.08% |
|
-8.88% |
|
$0.62 |
|
$-0.07 |
|
$-0.07 |
|